Computational Organic Chemistry with the University of Oxford and AstraZeneca

Fully Funded PhD studentship in Computational Organic Chemistry with the
University of Oxford and AstraZeneca

Industrial Sponsor: AstraZeneca
Oxford Supervisor: Dr Robert Paton (http://paton.chem.ox.ac.uk)

A fully funded PhD studentship with AstraZeneca as the industrial
collaborator is available at the University of Oxford to begin in
October 2011. This research project will explore C-H functionalization
with predictive computational methods. The research will be carried out
under the supervision of Dr. Robert Paton and the work will be carried
out in the Chemistry Research Laboratory at Oxford. Find out more about
ongoing research at: http://paton.chem.ox.ac.uk

Direct functionalization of unactivated C-H bonds is a powerful way to
increase molecular complexity and is of great interest to academia and
the pharmaceutical industry. This PhD project will investigate C-H
functionalization reactions using computational modelling techniques to
establish a set of general principles that may be used to design and
predict the usefulness of C-H functionalization for a given substrate.
The PhD student will have the opportunity to collaborate with
world-class theoretical and experimental co-workers in Oxford and
AstraZeneca and will have access to the computational resources of the
 
Oxford Supercomputing Centre.
The prospective student should be committed to and motivated by
chemistry, with aspirations to pursue a career in academia or the UK
chemical industry. Applicants should have, or expect, a first or second
class honours degree, or equivalent, in a relevant discipline
(Chemistry, Biochemistry, Physics). The studentship will cover the fees
and maintenance for 3 years for UK and EU citizens.
The Chemistry Research Laboratory is a state of the art research
facility at the University of Oxford. Opened in 2004, it has five floors
covering ~17,000 sq.m of laboratory and office space and cost £60
million to construct.

AstraZeneca is a global research-based biopharmaceutical company,
focusing on discovering, developing and marketing medicines for some of
the world’s most serious illnesses, including cancer, heart disease,
neurological disorders such as schizophrenia, respiratory disease and
infection.

For enquiries regarding the research project please contact Dr Paton:
robert.paton@chem.ox.ac.uk .
For further information please see:
http://www.chem.ox.ac.uk/graduatestudies/prospective.html
To apply please see here:
http://www.ox.ac.uk/admissions/postgraduate_courses/apply/index.html
For enquires relating to the application and admissions process please
contact:
Aga Borkowska, Graduate Studies Administrator:
graduate.studies@chem.ox.ac.uk
+44 (0) 1865 272569

The University of Oxford is an Equal Opportunities Employer.